Abstract
Drug delivery to the central nervous system (CNS) is a timely and challenging issue: 95% of the pharmacological drugs cannot be delivered to the brain. This is mainly due to the blood-brain barrier (BBB), a highly selective boundary that hampers the passage of most compounds into the CNS. To overcome this problem, several approaches exist to deliver a therapeutic drug to the brain that takes into account not only the chemical properties of the drug but also the type of transport used at the BBB. One of those strategies is the glucose-mediated drug delivery which will be the focus of the present review. Glucose-mediated drug delivery requires the attachment of glycosyl moieties to a drug and the use of endogenous glucose transporters as a way to circumvent the blood-brain barrier. Glycosylated drugs display improved cell penetrability, enhanced biodistribution, stability and low toxicity. Examples such as glycosylation of ibuprofen and different opioids result in an enhanced central effect and will be discussed.
Keywords: blood-brain barrier, central nervous system, drug delivery, glucose derivatives, glycosylation, cationized albumin, transferrin, Carrier-mediated, hexose, cell membranes, phosphosphorylation
Mini-Reviews in Medicinal Chemistry
Title:A Focus on Glucose-Mediated Drug Delivery to the Central Nervous System
Volume: 12 Issue: 4
Author(s): I. D. Serrano, M. M.B. Ribeiro, M. A.R.B. Castanho
Affiliation:
Keywords: blood-brain barrier, central nervous system, drug delivery, glucose derivatives, glycosylation, cationized albumin, transferrin, Carrier-mediated, hexose, cell membranes, phosphosphorylation
Abstract: Drug delivery to the central nervous system (CNS) is a timely and challenging issue: 95% of the pharmacological drugs cannot be delivered to the brain. This is mainly due to the blood-brain barrier (BBB), a highly selective boundary that hampers the passage of most compounds into the CNS. To overcome this problem, several approaches exist to deliver a therapeutic drug to the brain that takes into account not only the chemical properties of the drug but also the type of transport used at the BBB. One of those strategies is the glucose-mediated drug delivery which will be the focus of the present review. Glucose-mediated drug delivery requires the attachment of glycosyl moieties to a drug and the use of endogenous glucose transporters as a way to circumvent the blood-brain barrier. Glycosylated drugs display improved cell penetrability, enhanced biodistribution, stability and low toxicity. Examples such as glycosylation of ibuprofen and different opioids result in an enhanced central effect and will be discussed.
Export Options
About this article
Cite this article as:
I. D. Serrano, M. M.B. Ribeiro, M. A.R.B. Castanho , A Focus on Glucose-Mediated Drug Delivery to the Central Nervous System, Mini-Reviews in Medicinal Chemistry 2012; 12 (4) . https://dx.doi.org/10.2174/138955712799829302
DOI https://dx.doi.org/10.2174/138955712799829302 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Towards Prevention of Ovarian Cancer
Current Cancer Drug Targets Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
Current Neuropharmacology Quantum Dot-Based Nanoprobes for In Vivo Targeted Imaging
Current Molecular Medicine Lipoic Acid as a Potential Therapy for Chronic Diseases Associated with Oxidative Stress
Current Medicinal Chemistry β-Hydroxy-β-Methylbutyrate as a Countermeasure for Cancer Cachexia: A Cellular and Molecular Rationale
Anti-Cancer Agents in Medicinal Chemistry Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease
Current Alzheimer Research Molecular Mechanisms of Liver Cancer
Anti-Cancer Agents in Medicinal Chemistry Efficacy of Sofosbuvir Plus Ribavirin with or Without Peginterferon- Alfa in Treatment of a Cohort of Egyptian Patients with Hepatitis C Virus Infection
Infectious Disorders - Drug Targets Advances on Magnetic Nanocarriers Based on Natural Polymers
Current Pharmaceutical Design ING Proteins as Potential Anticancer Drug Targets
Current Drug Targets Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells
Clinical Cancer Drugs Exosomes and the Emerging Field of Exosome-Based Gene Therapy
Current Gene Therapy Growth Factor Changes in Cerebrospinal Fluid of Children with Mental Retardation before and after Neural Precursor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Synthesis and Anti-Proliferative Activity of New Biphenyle-Benzylidenethiazolidine- 2,4-dione Bis-Adducts Containing Various Heterocyclic Cores
Letters in Drug Design & Discovery Application of Mesenchymal Stem Cells to Age-related Neuronal Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Determinants of Longevity: Genetics, Biomarkers and Therapeutic Approaches
Current Pharmaceutical Design A Survey on the Applications of Implantable Micropump Systems in Drug Delivery
Current Drug Delivery Yeast Network and Report of New Stochastic-Credibility Cell Cycle Models
Current Bioinformatics Regulatory Triangle of Neurodegeneration, Adult Neurogenesis and MicroRNAs
CNS & Neurological Disorders - Drug Targets